Biovail Files 2nd Suit Over Watson's Aplenzin ANDA
Biovail Laboratories International SRL has filed a second patent infringement lawsuit to stop generic-drug maker Watson Pharmaceuticals Inc. from launching its own version of antidepressant Aplenzin....To view the full article, register now.
Already a subscriber? Click here to view full article